Guardant Health to Participate in Upcoming Investor Conferences

Guardant Health (Nasdaq: GH) will participate in three investor conferences in May–June 2026, including fireside chats and a presentation.

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

conferences

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

04/29/2026 - 04:05 PM EDT

PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences.

BofA Securities 2026 Healthcare Conference in Las Vegas, NV
Fireside chat on Tuesday, May 12^th at 10:40 a.m. Pacific Time

William Blair 46^th Annual Growth Stock Conference in Chicago, IL
Presentation on Tuesday, June 2^nd at 9:20 a.m. Central Time

Jefferies 2026 Global Healthcare Conference in New York, NY
Fireside chat on Wednesday, June 3^rd at 11:05 a.m. Eastern Time

Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.

Source: Guardant Health, Inc.